| Literature DB >> 33584793 |
Jin Ok Yang1,2, Min-Hyuk Choi3,4, Ji-Yong Yoon3, Jeong-Ju Lee3, Sang Ook Nam5, Soo Young Jun3, Hyeok Hee Kwon6, Sohyun Yun3, Su-Jin Jeon3,4, Iksu Byeon2, Debasish Halder3, Juhyun Kong5, Byungwook Lee2, Jeehun Lee7, Joon-Won Kang8, Nam-Soon Kim3,4.
Abstract
Lennox-Gastaut syndrome (LGS) is a severe type of childhood-onset epilepsy characterized by multiple types of seizures, specific discharges on electroencephalography, and intellectual disability. Most patients with LGS do not respond well to drug treatment and show poor long-term prognosis. Approximately 30% of patients without brain abnormalities have unidentifiable causes. Therefore, accurate diagnosis and treatment of LGS remain challenging. To identify causative mutations of LGS, we analyzed the whole-exome sequencing data of 17 unrelated Korean families, including patients with LGS and LGS-like epilepsy without brain abnormalities, using the Genome Analysis Toolkit. We identified 14 mutations in 14 genes as causes of LGS or LGS-like epilepsy. 64 percent of the identified genes were reported as LGS or epilepsy-related genes. Many of these variations were novel and considered as pathogenic or likely pathogenic. Network analysis was performed to classify the identified genes into two network clusters: neuronal signal transmission or neuronal development. Additionally, knockdown of two candidate genes with insufficient evidence of neuronal functions, SLC25A39 and TBC1D8, decreased neurite outgrowth and the expression level of MAP2, a neuronal marker. These results expand the spectrum of genetic variations and may aid the diagnosis and management of individuals with LGS.Entities:
Keywords: Lennox-Gastaut syndrome; Rare-diseases; epilepsy; genetic variation; whole-exome sequencing
Year: 2021 PMID: 33584793 PMCID: PMC7874053 DOI: 10.3389/fgene.2020.590924
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599